128 related articles for article (PubMed ID: 2571386)
21. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
Mielants H; Veys EM; Joos R
Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
[TBL] [Abstract][Full Text] [Related]
22. IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Granfors K
Ann Rheum Dis; 1995 Aug; 54(8):631-5. PubMed ID: 7677438
[TBL] [Abstract][Full Text] [Related]
23. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
[TBL] [Abstract][Full Text] [Related]
24. Sulphasalazine and ankylosing spondylitis: an open pilot study.
Coelho Andrade LE; Atra E; Bosi Ferraz M
Clin Exp Rheumatol; 1989; 7(6):661-2. PubMed ID: 2575477
[No Abstract] [Full Text] [Related]
25. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis.
Khanna Sharma S; Kadiyala V; Naidu G; Dhir V
Int J Rheum Dis; 2018 Jan; 21(1):308-314. PubMed ID: 28737251
[TBL] [Abstract][Full Text] [Related]
26. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.
Kinsella TD; Espinoza L; Vasey FB
J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743
[TBL] [Abstract][Full Text] [Related]
27. Sulphasalazine and ankylosing spondylitis.
McConkey B
Br J Rheumatol; 1990 Feb; 29(1):2-3. PubMed ID: 1968352
[No Abstract] [Full Text] [Related]
28. Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.
Hocini H; Iscaki S; Benlahrache C; Vitalis L; Chevalier X; Larget-Piet B; Bouvet JP
Ann Rheum Dis; 1992 Jun; 51(6):790-2. PubMed ID: 1616365
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of sulfasalazine in ankylosing spondylitis.
Ferraz MB; Tugwell P; Goldsmith CH; Atra E
J Rheumatol; 1990 Nov; 17(11):1482-6. PubMed ID: 1980310
[TBL] [Abstract][Full Text] [Related]
30. Microheterogeneity of alpha 1-antitrypsin in relation to the concentration of its complex with immunoglobulin A in the sera of patients with rheumatoid arthritis.
Hrycaj P; Nayyar S; Stanworth DR; Müller W
Clin Exp Rheumatol; 1996; 14(2):119-23. PubMed ID: 8737716
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of ankylosing spondylitis with salazosulfapyridine. A controlled double-blind study in 60 patients].
Dougados M; Boumier P; Amor B
Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):255-60. PubMed ID: 2884723
[TBL] [Abstract][Full Text] [Related]
32. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies.
van der Horst-Bruinsma IE; Zack DJ; Szumski A; Koenig AS
Ann Rheum Dis; 2013 Jul; 72(7):1221-4. PubMed ID: 23264358
[TBL] [Abstract][Full Text] [Related]
33. T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R; Sjöberg O
Clin Rheumatol; 1987 Dec; 6(4):545-52. PubMed ID: 2896558
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Xinfeng Capsule on AS Patients and Their Serum Immunoglobulin Subtypes and Peripheral Lymphocyte Autophagy].
Ye WF; Liu J; Wan L; Cao YX; Wang SH; Wang YL; Ruan LP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):310-6. PubMed ID: 27236888
[TBL] [Abstract][Full Text] [Related]
35. Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitis.
Magnus JH; Elverland HH; Olsen EG; Husby G
Scand J Rheumatol; 1993; 22(4):199-201. PubMed ID: 8102809
[TBL] [Abstract][Full Text] [Related]
36. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years.
Kirwan J; Edwards A; Huitfeldt B; Thompson P; Currey H
Br J Rheumatol; 1993 Aug; 32(8):729-33. PubMed ID: 8102305
[TBL] [Abstract][Full Text] [Related]
37. Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.
Damjanov N; Shehhi WA; Huang F; Kotak S; Burgos-Vargas R; Shirazy K; Bananis E; Szumski A; Llamado LJ; Mahgoub E
Rheumatol Int; 2016 May; 36(5):643-51. PubMed ID: 26968844
[TBL] [Abstract][Full Text] [Related]
38. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
Clegg DO; Reda DJ; Weisman MH; Blackburn WD; Cush JJ; Cannon GW; Mahowald ML; Schumacher HR; Taylor T; Budiman-Mak E; Cohen MR; Vasey FB; Luggen ME; Mejias E; Silverman SL; Makkena R; Alepa FP; Buxbaum J; Haakenson CM; Ward RH; Manaster BJ; Anderson RJ; Ward JR; Henderson WG
Arthritis Rheum; 1996 Dec; 39(12):2004-12. PubMed ID: 8961905
[TBL] [Abstract][Full Text] [Related]
39. Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R; Venge P
Ann Rheum Dis; 1987 May; 46(5):403-7. PubMed ID: 2884933
[TBL] [Abstract][Full Text] [Related]
40. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman JD; Sack KE; Davis JC
N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
